AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Opimet-G Tablet SR

Prescription Icon
Prescription Required

Marketer

Overseas Pharma Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Opimet-G Tablet SR

DiabetaComb SR tablets are a dual-action antidiabetic medication used to manage type 2 diabetes in adults. This formulation combines two agents to help regulate blood glucose levels. DiabetaComb SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing dietary adjustments, regular exercise, and weight management as recommended by your healthcare provider. Lifestyle choices are crucial in diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a quick-acting glucose source (e.g., sugary snacks or juice) to counter hypoglycemia and maintain regular mealtimes. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects are altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some patients. DiabetaComb SR is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) may be recommended by your physician.

Uses of Opimet-G Tablet SR

Adult-onset diabetes

Major Benefits of Opimet-G Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Opimet-G SR tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Opimet-G Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Opimet-G Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Opimet-G Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Opimet-G Tablet SR works:

Gliclazide and metformin are combined in the extended-release Opimet-G tablet to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Opimet-G Tablet SR and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Opimet-G Tablet SR during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in rare, life-threatening circumstances where the potential benefits significantly outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Opimet-G tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Opimet-G Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician. Opimet-G Tablet SR is contraindicated in patients exhibiting severe renal insufficiency. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Opimet-G Tablet SR to individuals with hepatic impairment. Dosage modification of Opimet-G Tablet SR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, Opimet-G Tablet SR should typically commence at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Opimet-G Tablet SR :

Should you forget a dose of Opimet-G Tablet SR, take it immediately if you remember. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Opimet-G Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Opimet-G Tablet SR

Opimet-G SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Opimet-G SR is not suitable for type 1 diabetes.
Opimet-G Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Opimet-G Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Opimet-G Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Opimet-G Tablet SR and seek immediate medical attention.
Prolonged Opimet-G Tablet SR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Opimet-G Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Opimet-G Tablet SR and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Opimet-G SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Opimet-G SR is not suitable for type 1 diabetes.
Opimet-G Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Opimet-G Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Opimet-G Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who do not consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Opimet-G Tablet SR and seek immediate medical attention.
Prolonged Opimet-G Tablet SR use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Opimet-G Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Opimet-G Tablet SR and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Opimet-G Tablet SR
57
MRP 70
18% off